Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: Percent reduction or target level?

Autor:	Fernando H. Y. Cesena, Raquel D. Conceição, Viviane A. Valente, Raul D. Santos, Márcio Sommer Bittencourt, Antonio G. Laurinavicius
Rok vydání:	2017
Předmět:	Cardiovascular event Relative risk reduction Adult Male medicine.medical_specialty Statin medicine.drug_class Population Hypercholesterolemia Clinical Investigations Low density lipoprotein cholesterol 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Risk Factors Internal medicine medicine Secondary Prevention Humans 030212 general & internal medicine education Aged education.field_of_study Atherosclerotic cardiovascular disease business.industry Anticholesteremic Agents Incidence Disease Management General Medicine Cholesterol LDL Middle Aged Survival Rate Target level Cardiovascular Diseases Number needed to treat lipids (amino acids peptides and proteins) Female Hydroxymethylglutaryl-CoA Reductase Inhibitors Cardiology and Cardiovascular Medicine business Brazil Follow-Up Studies Forecasting
Zdroj:	Clinical cardiology. 41(3)
ISSN:	1932-8737
Popis:	BACKGROUND: Recommendations for blood cholesterol management differ across different guidelines. HYPOTHESIS: Lipid‐lowering strategies based on low‐density lipoprotein‐cholesterol (LDL‐c) percent reduction or target concentration may have different effects on the expected cardiovascular benefit in intermediate‐risk individuals. METHODS: We selected individuals between 40 and 75 years of age with 10‐year risk for atherosclerotic cardiovascular disease (ASCVD) between 5.0% and
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e78eddbdf234776a15fb2562fee1dac https://pubmed.ncbi.nlm.nih.gov/29574925 Zobrazit plný text záznamu